MedTrace Logo

International Consortium Investigating Early Vitrectomy in Diabetic Macular Edema Patients

NCT02639507 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-03-26

No results posted yet for this study

Summary

The purpose of this research is to evaluate the effectiveness of vitrectomy for the treatment of diabetic macular edema. Diabetes is known to cause retinal blood vessels to leak, leading to swelling of the central retina (macula), and decreased vision. Removing the vitreous gel with vitrectomy surgery is known to decrease the swelling caused by diabetes. Diabetic retinopathy is often treated with laser or injections of medicine in to the eye.

Conditions

  • Diabetes With Diabetic Retinopathy With Macular Edema

Interventions

PROCEDURE

Vitrectomy

Sponsors & Collaborators

Principal Investigators

  • Michael W Stewart, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2020-03-31
Completion
2020-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02639507 on ClinicalTrials.gov